Medtronic to pay $23.5 million to settle kickback charge - Bring Me The News

Medtronic to pay $23.5 million to settle kickback charge

The Justice Department alleged that Medtronic funneled money to doctors who implanted pacemakers or defibrillators made by the company. A spokesman says Medtronic admits no wrongdoing in the settlement.
Author:
Publish date:

The Justice Department alleged that Medtronic funneled money to doctors who implanted pacemakers or defibrillators made by the company. A spokesman says Medtronic admits no wrongdoing in the settlement.

Next Up

Related

Feds close probe into Medtronic's marketing of its Infuse bone graft product

The U.S. Department of Justice spent four years looking into whether the Fridley-based manufacturer encouraged doctors to use the product in ways not described on the FDA-approved label. Medtronic denies any wrongdoing, but still faces civil lawsuits and agreed to pay $85 million in March to settle a federal securities lawsuit.

Medtronic cutting 220 jobs in Mounds View

Medtronic is eliminating jobs at the Mounds View facility that makes heart rhythm devices. Sales of the company's pacemakers and implantable defibrillators have been sluggish for years.

Medtronic pays out millions of dollars to department chief at UW-Madison

Some academic leaders at the university are questioning whether chairman Thomas Zdeblick can serve objectively after collecting tens of millions of dollars from Medtronic, a major medical device maker based in Minnesota. The Journal Sentinel reports UW Hospital has spent $27 million on Medtronic products between 2004 and 2010.

CEO: Medtronic's focus paying off

After a solid last year and last quarter, Medtronic Inc. CEO Omar Ishrak is reiterating that his company's commitment is to growth through globalization, innovation and enhancing value, not just creating new medical technology products. It's what Ishrak has consistently preached in the year-plus since he took the helm at the world's largest medical device company.

Medtronic loses appeal of patent infringement case

Medtronic says it is evaluating its next step after a court rejected the company's appeal of a $74 million patent infringement ruling. The ruling could eventually force Medtronic to stop making one of its heart valves if a competitor - Edwards Lifesciences - seeks an injunction.